Form 4: Aspira Women's Health Director Buys Shares & Warrants
Insider Transaction Report
Aspira Women's Health Director John D. Fraser increased his direct and indirect holdings through open market purchases of common stock and warrants.
Summary
- John D. Fraser, a Director of Aspira Women's Health Inc. (AWHL), reported transactions on September 17, 2025.
- Acquired 16,389 shares of common stock directly at a price of $0.45 per share.
- Acquired 12,292 warrants directly with an exercise price of $0.75 per share.
- The acquired warrants are exercisable immediately and expire on September 17, 2030.
- Following these transactions, Fraser directly owns 566,393 shares of common stock and 981,549 warrants.
- He also indirectly owns 291,554 shares of common stock through Seamark Capital.
Sentiment
Score: 7
Explanation: Insider buying by a director generally indicates confidence in the company's future prospects, especially when acquiring both common stock and warrants, suggesting a positive outlook from management.
Positives
- A director, John D. Fraser, increased his direct stake in the company by purchasing 16,389 shares of common stock at $0.45 per share.
- The director also acquired 12,292 warrants, which typically indicates a belief in future upside potential for the company's stock.
Stakeholder Impact
- Shareholders: May view the director's increased stake as a positive signal of confidence in the company's future performance and valuation.
Key Dates
| Date | Description |
|---|---|
| 09/17/2025 | Date of earliest transaction for common stock and warrants acquisition. |
| 09/17/2025 | Warrants became exercisable. |
| 09/18/2025 | Signature date of the reporting person. |
| 09/17/2030 | Warrant expiration date. |
Recommendation
holdThe director's purchase of common stock and warrants signals confidence in Aspira Women's Health's future. While this is a positive indicator, a single insider transaction report typically does not provide sufficient comprehensive financial or strategic information to warrant a 'buy' or 'sell' recommendation without further analysis of the company's fundamentals and market conditions. Therefore, a 'hold' recommendation is appropriate, suggesting investors monitor future developments.
Keywords
Aspira Women's Health, AWHL, John D. Fraser, Insider Trading, Form 4, Director Purchase, Common Stock, Warrants, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.